Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 23, 2025, Altamira Therapeutics (CYTO) has a market cap of $1.134 million USD. According to our data, Altamira Therapeutics is ranked No.9231 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 23, 2025 | $1.13 M |
171.49%
|
| Dec 31, 2024 | $0.42 M |
-96.82%
|
| Dec 29, 2023 | $13.15 M |
-96.41%
|
| Dec 30, 2022 | $0.37 B |
-86.64%
|
| Dec 31, 2021 | $2.74 B |
-30.73%
|
| Dec 31, 2020 | $3.96 B |
61.73%
|
| Dec 31, 2019 | $2.45 B |
-82.24%
|
| Dec 31, 2018 | $13.78 B |
-92.28%
|
| Dec 29, 2017 | $178.50 B |
-44.81%
|
| Dec 30, 2016 | $323.44 B |
-78.12%
|
| Dec 31, 2015 | $1.478 T |
25.38%
|
| Dec 31, 2014 | $1.179 T |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Turtle Beach Corp
HEAR
|
$0.35 B |
-0.022 B
|
USA
|
 Ameriprise Financial
AMP
|
$54.48 B |
0.000 M
|
USA
|
 Waterdrop Inc.
WDH
|
$0.44 B |
94.624 M
|
China
|
| Market Cap | = | CYTO Stock Price | * | CYTO Shares Outstanding |
| = | $0.17 | * | 3.78 M | |
| = | $1.13 M |